CAS 148218-14-8

Doxorubicin EP Impurity B HBr

CAS : 148218-14-8

Formule : C₂₉H₃₄BrNO₁₁·HBr

Couleur et forme : Red Solid

Masse moléculaire : 652.50 80.91

Ref: 4Z-D-349

14-Bromo, 13-Deoxo, 13,13-Dimethoxy Daunorubicin Hydrobromide (>85%)

Produit contrôlé

CAS : 148218-14-8

Applications (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione, is the metabolite of Doxorubicin (D558000), which is a neoplasm inhibitor,and an antineoplastic.
References Smith, T.H., et al.: J. Med. Chem., 22, 40 (1979); Di Marco, A., et al.: Cancer Chemother. Rep., (part 1), 53, 33 (1969), Mihich, E. and Ehrke, M.J.: Transplant. Proc., 16, 499 (1984),

Formule : C₂₉H₃₄BrNO₁₁·BrH

Degré de pureté : >85%

Couleur et forme : Neat

Masse moléculaire : 733.40

Ref: TR-A630405

Doxorubicin Imp B HBr salt

CAS : 148218-14-8

Doxorubicin Imp B HBr salt is a drug product that is custom synthesized for research and development. It's high purity, analytical, and natural are well suited for pharmacopoeia, drug development, and niche. Doxorubicin Imp B HBr salt has been shown to be metabolized through a number of metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid. The CAS No. 148218-14-8 is an impurity standard that can be used in HPLC analysis to determine the purity of Doxorubicin Imp B HBr salt.

Formule : C₂₉H₃₄BrNO₁₁BrH

Degré de pureté : Min. 95%

Masse moléculaire : 733.4 g/mol

Ref: 3D-AA145165